Five Hours Of Pain Relief Preclinical Study Shows Promising Results With This Non-Toxic CBD
| MYMDDelisted Stock | USD 1.82 0.02 1.09% |
About 62% of MYMD Old's investor base is looking to short. The analysis of current outlook of investing in MYMD Old suggests that many traders are alarmed regarding MYMD Old's prospects. The current market sentiment, together with MYMD Old's historical and current headlines, can help investors time the market. In addition, many technical investors use MYMD Old stock news signals to limit their universe of possible portfolio assets.
MYMD |
MyMD Pharmaceuticals, Inc. announced on Thursday the results from a preclinical study of its investigational cannabinoid Supera-CBD, a novel, synthetic, non-toxic cannabidiol analog.
Read at benzinga.com
 |
MYMD Old Fundamental Analysis
We analyze MYMD Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MYMD Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MYMD Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
MYMD Old is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
MYMD Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MYMD Old stock to make a market-neutral strategy. Peer analysis of MYMD Old could also be used in its relative valuation, which is a method of valuing MYMD Old by comparing valuation metrics with similar companies.
Peers
MYMD Old Related Equities
| UBX | Unity Biotechnology | 34.59 | ||||
| NBY | NovaBay Pharmaceuticals | 9.37 | ||||
| PASG | Passage Bio | 1.52 | ||||
| GOVX | GeoVax Labs | 1.36 | ||||
| KZR | Kezar Life | 1.06 | ||||
| AVIR | Atea Pharmaceuticals | 2.10 | ||||
| KROS | Keros Therapeutics | 2.22 | ||||
| KRON | Kronos Bio | 3.03 | ||||
| LRMR | Larimar Therapeutics | 3.43 | ||||
| LGND | Ligand Pharmaceuticals | 3.89 | ||||
| REPL | Replimune | 4.08 | ||||
| RXRX | Recursion Pharmaceuticals | 5.23 | ||||
| BOLT | Bolt Biotherapeutics | 5.26 | ||||
| XBIO | Xenetic Biosciences | 5.39 | ||||
| NVCT | Nuvectis Pharma | 5.83 | ||||
| ORIC | Oric Pharmaceuticals | 6.35 | ||||
| GOSS | Gossamer Bio | 7.62 | ||||
| LYEL | Lyell Immunopharma | 7.69 | ||||
| REVB | Revelation Biosciences | 8.62 | ||||
| LYRA | Lyra Therapeutics | 9.09 | ||||
| DSGN | Design Therapeutics | 11.02 | ||||
| SRZN | Surrozen | 12.96 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in MYMD Stock
If you are still planning to invest in MYMD Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MYMD Old's history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |